POLISTENA, B.; SPANDONARO, F.; CAPRA, R.; FANTACCINI, S.; SANTONI, L.; ZIMATORE, G.; GASPERINI, C. The societal impact of treatment with natalizumab of relapsing–remitting multiple sclerosis in Italian clinical practice: The Tysabri® PharmacoEconomics (TyPE) Study. Global and Regional Health Technology Assessment, [S. l.], v. 6, n. 1, 2019. DOI: 10.33393/grhta.2019.463. Disponível em: https://journals.aboutscience.eu/index.php/grhta/article/view/463. Acesso em: 22 jul. 2024.